An interventional study of Educational Intervention and Internet-Based Intervention in Cigarette Smoking-Related Carcinoma, sponsored by Roswell Park Cancer Institute. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Roswell Park Cancer Institute · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 371 studies in Cigarette Smoking with a site in United States — 68 open to participants now, 75 under way, 3 of them phase 3. Cigarette Smoking · United States.
Among the 371 studies in Cigarette Smoking with a site in United States, this one is the 40th largest by planned enrollment of the 340 interventional ones that give a count, is one of 19 that started in 2025, is one of 226 with no phase, reaches primary completion later than 3 of the 74 other live ones, and was the 368th registered.
477 studies on the registry are indexed under Cigarette Smoking; 87 are open to participants now.
Browse Cigarette Smoking studies →68 of the 371 studies in Cigarette Smoking with a site in United States are open now. Recruiting first, the newest first:
Roswell Park Cancer Institute · Sites in United States
Ages 18–30
Virginia Polytechnic Institute and State University · Sites in United States
Ages 21+
University of California, Irvine · Sites in United States
Ages 50–80
VA Office of Research and Development · Sites in United States
Ages 21+
Ohio State University Comprehensive Cancer Center · Sites in United States
Ages 21–50
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 62 Cigarette Smoking studies recruiting now, 38 (61%) set no upper age limit and 18 (29%) stop at 75 or younger; 1 takes children under 18; 33 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
371 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 35 · Phase 2 56 · Phase 3 10 · Phase 4 22
First in 1997; this study’s year is marked. 19 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 600 is above the median of 96 across 407 interventional studies indexed under Cigarette Smoking.
Median enrollment 96 across the 340 interventional studies, 159 across the 30 observational. Of the 280 that completed or were terminated, 137 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
20 of 371 have an industry lead sponsor. The 10 most frequent:
Roswell Park Cancer Institute is the lead sponsor of 419 studies on the registry; 65 are open to participants now.
Of its 38 completed or terminated interventional studies of FDA-regulated products, 21 (55%) have results posted.
Roswell Park Cancer Institute has 8 studies filed under Cigarette Smoking — fewer than ten, so there is no comparison to draw.
34 of the studies in Cigarette Smoking with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04176172Phase 3Abramson Cancer Center at Penn MedicineOptimizing Tobacco Use Treatment for PLWHA | 2026-11-30 |
| NCT05008848Phase 3Alliance for Clinical Trials in OncologyReaching Rural Cancer Survivors Who Smoke Using Text-Based Program | 2027-04-23 |
| NCT06945120Dana-Farber Cancer InstituteACT Lung Health Intervention: Phase Two | 2026-11-30 |
| NCT05836103Johns Hopkins Bloomberg School of Public HealthTesting the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation | 2026-11-30 |
| NCT05707871Wake Forest University Health SciencesCardiovascular Effects of Very Low Nicotine Content Cigarettes | 2026-12 |
Add all 34 to your calendar (.ics) → With an account.
Among the 371 studies in Cigarette Smoking with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This clinical trial compares the impact of receiving educational materials containing relevant content about risks from smoking menthol cigarettes which include links to the New York (NY) Smoke-Free website by text message or mail in people who smoke menthol cigarettes. The NY Smoke-Free website includes tailored content developed specifically for menthol smokers and provides resources designed to resonate with the experiences of menthol smokers and address the unique challenges they face in quitting. Delivering tailored educational materials by text message or mail may increase interaction with information about menthol cigarettes and smoking cessation resources compared to those who do not receive the educational messaging.
PRIMARY OBJECTIVES:
I. Assess participant interaction with an educational message about menthol cigarettes by tracking visits to the Quitline website.
II. Assess participant interaction with the educational message delivered by text message with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web site.
III. Assess participant interaction with the educational message delivery by mail with a direct link to information about menthol cigarettes by tracking visits to the Quitline Web.
OUTLINE: Participants are randomized to 1 of 3 groups.
GROUP I: Participants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and quick response (QR) code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
GROUP II: Participants receive standard Quitline materials in the mail on study.
GROUP III: Participants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants receive standard Quitline materials in the mail on study.
Behavioral: Smoking Cessation Intervention
Participants receive an educational flyer by mail along with the standard Quitline materials on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
Other: Educational Intervention · Other: Internet-Based Intervention · Behavioral: Smartphone Application-based Intervention · Behavioral: Smoking Cessation Intervention
Participants receive an educational message by text along with the standard Quitline materials by mail on study. Participants receive access to a website and QR code directing them to culturally tailored information about menthol cigarettes and cessation on the NY Smoke-Free website.
Other: Internet-Based Intervention · Behavioral: Smartphone Application-based Intervention · Behavioral: Smoking Cessation Intervention · Other: Text Message-Based Navigation Intervention
Receive an educational flyer by mail
Also known as: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Receive access to a website
Receive access to a QR code
Also known as: Smartphone App-based Intervention, Smartphone Intervention, Smartphone-based Intervention
Receive standard Quitline materials
Also known as: Smoking and Tobacco Use Cessation Interventions
Receive an educational message by text
Also known as: Automated Text Message-Based Navigation, Text Message-Based Navigation
Engagement with quick response (QR) code scans
QR code will be scanned will be tracked through unique uniform resource locator assigned. Each scan will be documented, allowing for the counting of interactions (Poisson) directly affiliated with the materials distributed. Also, binary (yes/no) (Did the participant interact at least once). Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).
Time frame: Up to 12 months
Website Utilization
total number of visits, unique visitors,
Time frame: Up to 12 months
Interactions with online resources
Interactions with online resources will include the number of clicks on website, and time spent on various pages. Will be analyzed using chi-square tests or Fisher's exact tests. Bonferroni's correction will be used to adjust for three pairwise comparisons (alpha=0.05/3).
Time frame: Up to 12 months
Website utilization
Duration of sessions
Time frame: Up to 12 months
Number of website interactions from the mailed flyer
Will measure participant engagement with the menthol educational materials.
Time frame: Up to 12 months
Number of QR code interactions from the mailed flyer
Will measure participant engagement with the menthol educational materials.
Time frame: Up to 12 months
Number of website interactions from the text message
Will measure participant engagement with the menthol educational materials.
Time frame: Up to 12 months
Number of QR code interactions from the text message
Will measure participant engagement with the menthol educational materials.
Time frame: Up to 12 months
Duration spent on the cessation website
Will assess depth of engagement.
Time frame: Up to 12 months
Number of pages or resources accessed on the website
Will evaluate participant utilization of the content.
Time frame: Up to 12 months
Ran from Aug 2025 to primary completion in Dec 2025, 4 months.
Of 185 non-industry interventional studies with no phase under Cigarette Smoking, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 33. This study's 4 months is below that.
Counting every sponsor, half of 192 studies reached it within 20 months; a quarter within 8 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Roswell Park Cancer Institute →